Chin Fatt, Cherise R.
Asbury, Sarah
Jha, Manish K. http://orcid.org/0000-0002-2764-2391
Minhajuddin, Abu
Sethuram, Sangita
Mayes, Taryn http://orcid.org/0000-0002-5992-6081
Kennedy, Sidney H. http://orcid.org/0000-0001-5339-7185
Foster, Jane A. http://orcid.org/0000-0002-8579-4705
Trivedi, Madhukar H. http://orcid.org/0000-0002-2983-1110
Funding for this research was provided by:
Hersh Foundation
Ontario Brain Institute
Article History
Received: 3 January 2023
Revised: 25 January 2023
Accepted: 24 March 2023
First Online: 28 April 2023
Conflict of interest
: Dr. Trivedi has served as a consultant or advisor for Alkermes Inc., Alto Neuroscience Inc, Axsome Therapeutics, Boegringer Ingelheim, GH Research, GreenLight VitalSign6 Inc, Heading Health, inc., Janssen Pharmaceutical, Legion Health, Merck Sharp & Dohme Corp., Mind Medicine Inc., Navitor, Neurocrine Biosciences Inc., Noema Pharma AG, Orexo US Inc., Otsuka Canada Pharmaceutical Inc, Otsuka Pharmaceutical Development & Commercialization, Inc. (MDD Section Advisor), SAGE Therapeutics, Signant Health, and Takeda Pharmaceuticals Inc. He receives editorial compensation from Oxford University Press. Dr. Jha has received contract research grants from Acadia Pharmaceuticals and Janssen Research & Development, educational grant to serve as Section Editor of the Psychiatry & Behavioral Health Learning Network, consultant fees from Eleusis Therapeutics US, Inc, and honoraria for CME presentations from North American Center for Continuing Medical Education and Global Medical Education. Dr. Foster has served on the Scientific Advisory Board for MRM Health NL and has received consulting/speaker fees from Klaire Labs, Takeda Canada and Rothman, Benson, Hedges Inc. Dr. Kennedy has acted in anadvisory role for Allergan, Alkermes, Janssen, Lundbeck, Lundbeck Institute, Otsuka, Pfizer, Servier and Sunovion; has been a speaker for Allergan, Lundbeck, Otsuka, Servier, Sun and Sunovion; has received research grants from the Ontario Brain Institute, Ontario Research Foundation, CIHR, Brain Canada, Janssen, Lundbeck, Otsuka, Pfizer and Servier; and has been a clinical trial investigator in studies sponsored by Janssen, Lundbeck, Pfizer, Abbott and SPOR. He holds stock in Field Trip Health. Dr. Chin Fatt, Dr. Minhajuddin, and Mrs. Asbury have no conflicts of interest to report.